InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
2
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-32.9%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the full record of transactions filed by Howell Peyton R. Officer active across 2 companies, notably TANDEM DIABETES CARE INC. In total, 9 disclosures have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €91k. Activity tracked since 3 August 2021. The latest transaction was filed on 22 May 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Howell Peyton R
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
4,387 股@ US$20.6421.0% 占其流量Common StockSEC:0001438133-25-000105:0
4,434 股@ US$51.7355.4% 占其流量Common StockSEC:0001438133-24-000126:0
949 股0Common StockSEC:0001438133-23-000157:0
2,757 股0Common StockSEC:0001438133-23-000106:0
3,000 股@ US$30.16421.8% 占其流量Common StockSEC:0001438133-23-000090:0
标准退出：2023年8月15日 (T+90)
949 股0Common StockSEC:0001438133-22-000183:0
1,653 股0Common StockSEC:0001438133-22-000097:0
100 股@ US$75.20971.9% 占其流量Common StockSEC:0001438133-22-000067:0
标准退出：2022年8月4日 (T+90)
948 股0Common StockSEC:0001438133-21-000123:0
9 条申报中的 9 条
About Howell Peyton R
Howell Peyton R is a declarant and a Director at Tandem Diabetes Care INC, with 9 filings in total. In the 9 most recent sampled filings, the total buy amount is EUR 90628, the total sell amount is EUR 0, the date range runs from 2021-08-05 to 2025-05-23, and the most common transaction nature is Option exercise.
